Pine River Capital Management’s Sinovac Biotech, Ltd SVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-106,198
Closed -$627K 520
2016
Q3
$627K Sell
106,198
-441,701
-81% -$2.6M 0.01% 366
2016
Q2
$3.25M Buy
547,899
+362,856
+196% +$2.22M 0.53% 15
2016
Q1
$1.18M Buy
+185,043
New +$1.11M 0.02% 373
2015
Q4
Sell
-525,848
Closed -$2.67M 834
2015
Q3
$2.67M Sell
525,848
-569,193
-52% -$3.02M 0.03% 248
2015
Q2
$5.75M Hold
1,095,041
0.06% 215
2015
Q1
$5.43M Hold
1,095,041
0.07% 196
2014
Q4
$5.73M Hold
1,095,041
0.07% 183
2014
Q3
$5.27M Buy
1,095,041
+912,676
+500% +$4.9M 0.06% 266
2014
Q2
$1.03M Buy
182,365
+116,881
+178% +$710K 0.02% 540
2014
Q1
$471K Sell
65,484
-429,162
-87% -$2.84M 0.01% 508
2013
Q4
$3.03M Sell
494,646
-57,352
-10% -$346K 0.04% 358
2013
Q3
$3.3M Sell
551,998
-294,556
-35% -$1.41M 0.04% 314
2013
Q2
$3.33M Buy
+846,554
New +$3.15M 0.05% 279

Other funds holding SVA

Pine River Capital Management's SVA Position: Q4 2016 in Review

Pine River Capital Management sold out of Sinovac Biotech, Ltd (SVA) in Q4 2016, closing a stake of 106,198 shares — an estimated $627K sold.

Pine River Capital Management first reported a position in SVA in Q2 2013 and held it in 13 quarters. The position peaked at $5.75M in Q2 2015. 38 funds tracked by Wall St. Rank hold SVA as of Q4 2016.

  • Pine River Capital Management reported no remaining Sinovac Biotech, Ltd position as of Q4 2016 after selling out during the quarter.
  • Pine River Capital Management sold 106,198 Sinovac Biotech, Ltd shares in Q4 2016, an estimated $627K.
  • Pine River Capital Management first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 13 quarters.
  • Pine River Capital Management's Sinovac Biotech, Ltd position peaked at $5.75M in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2016.

Based on Pine River Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.